{"schema_version":"secwatch.filing_event.v1","accession":"0001819790-26-000043","form_type":"8-K","ticker":"TARS","cik":"0001819790","company_name":"Tarsus Pharmaceuticals, Inc.","filed_at":"2026-06-29T20:19:53+00:00","discovered_at":"2026-06-29T20:21:00.395586+00:00","generated_at":"2026-06-29T20:21:06.190416+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Tarsus shareholders elect four Class III directors, approve exec comp, ratify auditor","bullets":["Wendy Yarno, Andrew Goldberg, Scott Morrison, David Pyott elected as Class III directors.","Advisory vote on named executive officer compensation approved with 34.5M for, 0.24M against.","Ratification of Ernst & Young as independent auditor for FY2026 approved with 38.2M for.","Meeting held June 25, 2026; 38.2M shares voted out of 43.0M outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001819790-26-000043","json":"https://secwatch.observer/filing/0001819790-26-000043.json","markdown":"https://secwatch.observer/filing/0001819790-26-000043.md","text":"https://secwatch.observer/filing/0001819790-26-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819790/000181979026000043/0001819790-26-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819790/000181979026000043/tars-20260625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T20:21:06.190416+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}